Related Experiment Videos
Matrix metalloproteinases in inflammatory myopathies: enhanced immunoreactivity near atrophic myofibers
B G H Schoser1, D Blottner, H-J Stuerenburg
1Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximillians University Munich, Munich, Germany. benedikt.schoser@fbs.med.uni-muenchen.de
Objectives:
To further examine the role of proteolytic enzyme expression of matrix metalloproteinases (MMP) and T-cell markers in inflammatory myopathies and controls.
Material And Methods:
We studied the expression of MMP-2, MMP-7, and MMP-9 in 19 cases of inflammatory myopathies and controls using immunocytochemistry.
Results:
Inflammatory myopathies showed distinct patterns of up-regulation of MMP. MMP-9 was strongly expressed in atrophic myofibers in all inflammatory myopathies. MMP-2 immunoreactivity was similar in its distribution, however, to a weaker intensity. In dermatomyositis the perifascicular atrophy showed pronounced MMP-9 immunoreactivity, probably reflecting denervated patterns of myofibers. Moreover, MMP-7 strongly immunolabeled invaded myofibers in polymyositis cases only.
Conclusion:
These patterns confirm, that MMP-7 up-regulation is prominent in PM, while MMP-2 immunoreactivity is only slightly elevated in inflamed muscle. In general, MMP-9 up-regulation appears to be an important additional molecular event in the multistep process of all inflammatory myopathies.
Insights
Matrix metalloproteinases (MMP) play a role in inflammatory myopathies. MMP-9 is upregulated in atrophic myofibers, while MMP-7 is prominent in polymyositis, indicating their involvement in muscle disease.
Area of Science:
- Muscle pathology
- Immunohistochemistry
- Proteolytic enzymes
Background:
- Inflammatory myopathies are debilitating autoimmune diseases affecting muscle.
- Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and degradation.
- Understanding MMP roles in myopathies is crucial for therapeutic development.
Purpose of the Study:
- To investigate the expression patterns of MMP-2, MMP-7, and MMP-9 in inflammatory myopathies.
- To correlate MMP expression with specific pathological features and disease subtypes.
- To elucidate the role of MMPs in the pathogenesis of inflammatory myopathies.
Main Methods:
- Immunocytochemistry was used to analyze MMP expression.
- Study included 19 cases of inflammatory myopathies and control samples.
- Specific MMPs examined were MMP-2, MMP-7, and MMP-9.
Main Results:
- All inflammatory myopathies showed increased MMP expression.
- MMP-9 was highly expressed in atrophic myofibers across all cases.
- MMP-7 specifically labeled invaded myofibers in polymyositis, while MMP-2 showed weaker, broader distribution.
Conclusions:
- MMP-7 upregulation is characteristic of polymyositis.
- MMP-9 upregulation is a significant molecular event in the pathogenesis of inflammatory myopathies.
- MMP-2 expression is only slightly elevated in inflamed muscle tissue.